Literature DB >> 35857592

Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality.

Soichi Sano1,2, Keita Horitani1, Hayato Ogawa1, Jonatan Halvardson3, Nicholas W Chavkin1,4, Ying Wang1, Miho Sano1, Jonas Mattisson3, Atsushi Hata5, Marcus Danielsson3, Emiri Miura-Yura1, Ammar Zaghlool3, Megan A Evans1, Tove Fall6, Henry N De Hoyos1, Johan Sundström7, Yoshimitsu Yura1, Anupreet Kour1, Yohei Arai1, Mark C Thel1, Yuka Arai1, Josyf C Mychaleckyj8, Karen K Hirschi4, Lars A Forsberg3,9, Kenneth Walsh1.   

Abstract

Hematopoietic mosaic loss of Y chromosome (mLOY) is associated with increased risk of mortality and age-related diseases in men, but the causal and mechanistic relationships have yet to be established. Here, we show that male mice reconstituted with bone marrow cells lacking the Y chromosome display increased mortality and age-related profibrotic pathologies including reduced cardiac function. Cardiac macrophages lacking the Y chromosome exhibited polarization toward a more fibrotic phenotype, and treatment with a transforming growth factor β1-neutralizing antibody ameliorated cardiac dysfunction in mLOY mice. A prospective study revealed that mLOY in blood is associated with an increased risk for cardiovascular disease and heart failure-associated mortality. Together, these results indicate that hematopoietic mLOY causally contributes to fibrosis, cardiac dysfunction, and mortality in men.

Entities:  

Keywords:  clonal hematopoiesis

Mesh:

Substances:

Year:  2022        PMID: 35857592      PMCID: PMC9437978          DOI: 10.1126/science.abn3100

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  26 in total

Review 1.  Fibrosis--a common pathway to organ injury and failure.

Authors:  Don C Rockey; P Darwin Bell; Joseph A Hill
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

2.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.

Authors:  José J Fuster; Susan MacLauchlan; María A Zuriaga; Maya N Polackal; Allison C Ostriker; Raja Chakraborty; Chia-Ling Wu; Soichi Sano; Sujatha Muralidharan; Cristina Rius; Jacqueline Vuong; Sophia Jacob; Varsha Muralidhar; Avril A B Robertson; Matthew A Cooper; Vicente Andrés; Karen K Hirschi; Kathleen A Martin; Kenneth Walsh
Journal:  Science       Date:  2017-01-19       Impact factor: 47.728

3.  Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.

Authors:  Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2007-09-20       Impact factor: 4.962

4.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

5.  Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.

Authors:  Gavin A Lewis; Susanna Dodd; Dannii Clayton; Emma Bedson; Helen Eccleson; Erik B Schelbert; Josephine H Naish; Beatriz Duran Jimenez; Simon G Williams; Colin Cunnington; Fozia Zahir Ahmed; Anne Cooper; Stuart Russell; Theresa McDonagh; Paula R Williamson; Christopher A Miller
Journal:  Nat Med       Date:  2021-08-12       Impact factor: 53.440

6.  Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer.

Authors:  Ayako Fujiwara; Soichiro Funaki; Eriko Fukui; Kenji Kimura; Takashi Kanou; Naoko Ose; Masato Minami; Yasushi Shintani
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

7.  Genetic predisposition to mosaic Y chromosome loss in blood.

Authors:  Lars A Forsberg; John R B Perry; Deborah J Thompson; Giulio Genovese; Jonatan Halvardson; Jacob C Ulirsch; Daniel J Wright; Chikashi Terao; Olafur B Davidsson; Felix R Day; Patrick Sulem; Yunxuan Jiang; Marcus Danielsson; Hanna Davies; Joe Dennis; Malcolm G Dunlop; Douglas F Easton; Victoria A Fisher; Florian Zink; Richard S Houlston; Martin Ingelsson; Siddhartha Kar; Nicola D Kerrison; Ben Kinnersley; Ragnar P Kristjansson; Philip J Law; Rong Li; Chey Loveday; Jonas Mattisson; Steven A McCarroll; Yoshinori Murakami; Anna Murray; Pawel Olszewski; Edyta Rychlicka-Buniowska; Robert A Scott; Unnur Thorsteinsdottir; Ian Tomlinson; Behrooz Torabi Moghadam; Clare Turnbull; Nicholas J Wareham; Daniel F Gudbjartsson; Yoichiro Kamatani; Eva R Hoffmann; Steve P Jackson; Kari Stefansson; Adam Auton; Ken K Ong; Mitchell J Machiela; Po-Ru Loh; Jan P Dumanski; Stephen J Chanock
Journal:  Nature       Date:  2019-11-20       Impact factor: 49.962

8.  Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models.

Authors:  Soichi Sano; Ying Wang; Megan A Evans; Yoshimitsu Yura; Miho Sano; Hayato Ogawa; Keita Horitani; Heather Doviak; Kenneth Walsh
Journal:  J Vis Exp       Date:  2019-10-03       Impact factor: 1.355

9.  The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.

Authors:  Yoshimitsu Yura; Emiri Miura-Yura; Yasufumi Katanasaka; Kyung-Duk Min; Nicholas Chavkin; Ariel H Polizio; Hayato Ogawa; Keita Horitani; Heather Doviak; Megan A Evans; Miho Sano; Ying Wang; Katharina Boroviak; George Philippos; Ana Filipa Domingues; George Vassiliou; Soichi Sano; Kenneth Walsh
Journal:  Circ Res       Date:  2021-07-28       Impact factor: 23.213

10.  Loss of Y and clonal hematopoiesis in blood-two sides of the same coin?

Authors:  Viktor Ljungström; Jonas Mattisson; Jan P Dumanski; Panagiotis Baliakas; Lars A Forsberg; Jonatan Halvardson; Tatjana Pandzic; Hanna Davies; Edyta Rychlicka-Buniowska; Marcus Danielsson; Paul Lacaze; Lucia Cavelier
Journal:  Leukemia       Date:  2021-11-01       Impact factor: 11.528

View more
  2 in total

1.  Loss of Y chromosome promotes cardiac fibrosis.

Authors:  Katie Kingwell
Journal:  Nat Rev Drug Discov       Date:  2022-09       Impact factor: 112.288

Review 2.  Individual Genetic Heterogeneity.

Authors:  Mauno Vihinen
Journal:  Genes (Basel)       Date:  2022-09-10       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.